Pfizer (PFE: 17.68, -0.30, -1.67%) has launched a new effort in connection with various pharmacies to draw attention to the risks associated with counterfeit prescription drugs.
The campaign comes amid growing concerns over illegitimate drugs and a recent spike in online purchases of them. Worldwide sales of counterfeit medicines were estimated to exceed $75 billion last year, an increase of 90% since 2005.
The announcement also comes on the same day a Boeing (BA: 60.51, -1.86, -2.98%) plant was raided by the FBI and DEA, leading to the arrest of 23 individuals and chargers against another 14 for illegally distributing or possessing prescription drugs.
The New York-based pharmaceutical giant warned that counterfeit medicines could cause serious health consequences, either because they include dangerous substances such as rat poison or lead paint, or because they do not include the appropriate amount of ingredients as approved by the FDA.
Read the full article by Jennifer Booton at foxbusiness.com
No comments:
Post a Comment